Roswell Park Comprehensive Cancer Center is leading the nation in bringing a lung cancer therapy developed in Cuba to the United States. The Roswell Park Alliance Foundation has committed donated funds to enable the rapid startup of the initial clinical trials of the immunotherapy treatment.

You can be a part of our commitment to help bring CIMAvax to the bedsides of lung cancer patients at Roswell Park, and across the country, as quickly as possible.

Proof already exists that it works for many patients. But, we need continued philanthropic support to further test the immunotherapy at Roswell Park so that we can improve the treatment of lung cancer and maintain the momentum of this important historic initiative.

Your support gives hope to lung cancer patients, especially those at high risk for recurrence. And, with your help, Roswell Park will be closer to investigating other potential uses of CIMAvax-- not only for advanced lung cancer, but also for patients at high risk for developing lung cancer and applications for other disease sites, starting with colon, head and neck, prostate, breast and pancreatic cancers.

To learn about other philanthropic opportunities to support this exciting venture, please call Director of Individual Giving, Kim Guido at 716-845-1338.

Please consider donating today!